Analysis of Outcomes In Adolescents and Young Adults (AYA) with Chronic Myeloid Leukemia (CML) Treated with Upfront Tyrosine Kinase Inhibitors (TKI)

被引：0
|
作者：
Pemmaraju, Naveen [1 ]
Kantarjian, Hagop [2 ]
Shan, Jianqin [2 ]
Jabbour, Elias [2 ]
Quintas-Cardama, Alfonso
Verstovsek, Srdan
Ravandi, Farhad
Wierda, William G. [2 ]
O'Brien, Susan [2 ]
Cortes, Jorge E. [2 ]
机构：
[1] MD Anderson, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：527 / 528
页数：2
相关论文
共 50 条
  • [1] Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy
    Pemmaraju, Naveen
    Kantarjian, Hagop
    Shan, Jianqin
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Verstovsek, Srdan
    Ravandi, Farhad
    Wierda, William
    O'Brien, Susan
    Cortes, Jorge
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (07): : 1029 - 1035
  • [2] Treatment of chronic myeloid leukemia (CML) in children and adolescents in the era of tyrosine kinase inhibitors (TKI)
    Suttorp, M.
    Tauer, J. T.
    Nowasz, C.
    Krumbolz, M.
    von Neuhoff, N.
    Glauche, I
    Schlegelberger, B.
    Metzler, M.
    Thiede, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 301 - 301
  • [3] Tyrosine kinase inhibitors (TKI): a new revolution in the treatment of chronic myeloid leukemia (CML)
    Aviles-Vazquez, Socrates
    Chavez-Gonzalez, Antonieta
    Mayani, Hector
    GACETA MEDICA DE MEXICO, 2013, 149 (06): : 646 - 654
  • [4] Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors
    Nishiyama-Fujita, Yuriko
    Nakazato, Tomonori
    Iriyama, Noriyoshi
    Tokuhira, Michihide
    Ishikawa, Maho
    Sato, Eriko
    Takaku, Tomoiku
    Sugimoto, Keiji
    Fujita, Hiroyuki
    Fujioka, Isao
    Tsuchiya, Shun
    Kimura, Yuta
    Iwanaga, Eisaku
    Komatsu, Norio
    Asou, Norio
    Kizaki, Masahiro
    Hatta, Yoshihiro
    Kawaguchi, Tatsuya
    ANNALS OF MEDICINE, 2022, 54 (01) : 1244 - 1254
  • [5] Survival outcomes of sustained MR4.5 in patients with chronic myeloid leukemia (CML) treated with various tyrosine kinase inhibitors (TKI).
    Hu, Boyu
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Borthakur, Gautam
    Kadia, Tapan M.
    Ferrajoli, Alessandra
    Wierda, William G.
    Garcia-Manero, Guillermo
    Daver, Naval Guastad
    Pemmaraju, Naveen
    Dellasala, Sara
    Pierce, Sherry
    Jabbour, Elias
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Outcomes of Chronic Phase Chronic Myeloid Leukemia (CP-CML) after Sequential Treatment with Tyrosine Kinase Inhibitors (TKI)
    Kong, Jee Hyun
    Winton, Elliott F.
    Heffner, Leonard
    Gaddh, Manila
    Hill, Brittany
    Arellano, Martha L.
    El-Rassi, Fuad
    Kim, Audrey
    Kota, Vamsi
    BLOOD, 2017, 130
  • [7] Estimated Glomerular Filtration Rate Changes In Patients (Pts) With Chronic Myeloid Leukemia (CML) Treated With Tyrosine Kinase Inhibitors (TKI)
    Yilmaz, Musa
    Kantarjian, Hagop M.
    Quintas-Cardama, Alfonso
    O'Brien, Susan
    Burger, Jan A.
    Ferrajoli, Alessandra
    Borthakur, Gautam
    Ravandi, Farhad
    Pierce, Sherry
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [8] Incidence, Interpretation and Management of Liver Function Abnormalities in Patients with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKI)
    Robertson, Harry F.
    Orovboni, Victoria
    Bahk, Jeeyune
    Szydlo, Richard
    Fernando, Fiona R.
    Khan, Afzal
    Toma, Sarmad
    Hayden, Chloe
    Claudiani, Simone
    Innes, Andrew J.
    Milojkovic, Dragana
    Apperley, Jane F.
    BLOOD, 2023, 142
  • [9] Incidence and Outcomes of Chronic Myeloid Leukemia (CML) Patients (pts) with Other Chromosomal Abnormalities (OCA) Treated with Second Generation Tyrosine Kinase Inhibitors (TKI)
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Burton, Elizabeth M.
    Dellasala, Sara E.
    Pierce, Sherry A.
    Kornblau, Steven M.
    Verstovsek, Srdan
    O'Brien, Susan
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [10] Outcome of Patients (pts) with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKI) Who Have a History of Prior Malignancies
    Koller, Paul B.
    Kantarjian, Hagop M.
    Koller, Charles
    Jabbour, Elias
    O'Brien, Susan
    Verstovsek, Srdan
    Borthakur, Gautam
    Estrov, Zeev
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    BLOOD, 2011, 118 (21) : 1618 - 1618
12345